Moreover, statistical analysis indicated that the reduced expression of CHIP was negatively associated with survival in pancreatic cancer patients and it was one of the independent risk factors that affected the prognosis in pancreatic cancer patients. This evidence concerns the gene STUB1 and pancreatic neoplasm.